Dr. Reddy’s Laboratories (ASX: RDY) — Company Overview, News & Financial Data
Dr. Reddy’s Laboratories is a global pharmaceutical company providing affordable medicines across various therapeutic areas.
Dr. Reddy’s Laboratories
Dr. Reddy’s Laboratories is a global pharmaceutical company headquartered in India that operates across four primary business segments: Generics, Active Pharmaceutical Ingredients (API) & Services, Innovative Medicines, and Consumer Health. The company develops, manufactures, and markets generic pharmaceuticals, active pharmaceutical ingredients, biosimilars, and over-the-counter health solutions globally. Its product portfolio spans major therapeutic areas including oncology, gastroenterology, cardiovascular, central nervous system, and pain management. Dr. Reddy’s Laboratories commercializes its products across major global markets including India, North America, Europe, and various emerging markets through internal development, manufacturing capabilities, and strategic global partnerships.
Snapshot
Operations
Products and/or services of Dr. Reddy’s Laboratories
- Generics: Development, manufacturing, and global commercialization of generic prescription pharmaceuticals including unbranded generic drugs and branded generics across major markets such as North America, India, Europe, and emerging markets across diverse therapeutic areas.
- Active Pharmaceutical Ingredients & Services: Production and worldwide distribution of active pharmaceutical ingredients, custom synthesis, contract development, and research support for generic drug developers and pharmaceutical companies across international commercial markets.
- Biosimilars: In-house development, biologics manufacturing, and global commercialization of biological products and biosimilar monoclonal antibodies, including rituximab and bevacizumab, for oncology and autoimmune indications across India, Europe, and North America.
- Consumer Health: Commercialization and global distribution of over-the-counter prescription-free medicines, dietary nutrition products, wellness treatments, and consumer healthcare solutions sold directly through retail pharmacies, retail outlets, and digital distribution channels.
- Innovative Medicines: Development and commercialization of proprietary specialty formulations, novel chemical entities, and licensed innovative therapeutics focused primarily on oncology and inflammatory conditions through specialized research divisions and global partnerships.
- Vaccines & In-Licensing Partnerships: Commercial promotion and distribution of third-party licensed vaccines, specialized pharmaceuticals, and novel prevention treatments through exclusive distribution partnerships with global biopharmaceutical companies across priority healthcare markets.
Dr. Reddy’s Laboratories executive team
- Mr. Gunupati Venkateswara Prasad B.E.Co-Chairman, MD & Member of Management Council
- Mr. Kallam Satish Reddy B.Tech., M.S.Chairman of the Board & Member of the Management Council
- Mr. Erez Israeli M.B.A.CEO & Member of the Management Council
- Mr. Mannam VenkatanarasimhamCFO & Member of the Management Council
- Mr. Krishna K. Venkatesh B.Pharma M.S.Global Head of Quality and Pharmacovigilance & Member of the Management Council
- Mr. Deepak Sapra M.B.A.Global Head of Pharmaceutical Services and Active Ingredients & Member of Management Council
- Mr. Motupalli Venkata Ramana M.B.A.CEO of Branded Markets - India & Emerging Countries and Member of Management Council
- Ms. Archana Bhaskar B.Sc., M.B.A.EVP, Head of Corporate Communications & Member of Management Council
- Mr. Sanjay Sharma B.Tech.Executive VP, Global Head of Global Manufacturing & Member of Management Council
- Mr. Patrick Aghanian B.A., M.B.A.Head of Generics, Europe & Consumer Health and Member of Management Council